| Current use of and trends in hematopoietic cell transplantation in the United States A D'Souza, C Fretham, SJ Lee, M Arora, J Brunner, S Chhabra, S Devine, ... Biology of Blood and Marrow Transplantation 26 (8), e177-e182, 2020 | 415 | 2020 |
| Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study K Fleischhauer, BE Shaw, T Gooley, M Malkki, P Bardy, JD Bignon, ... The lancet oncology 13 (4), 366-374, 2012 | 380 | 2012 |
| D iagnosis and management of acute graft‐versus‐host disease FL Dignan, A Clark, P Amrolia, J Cornish, G Jackson, P Mahendra, ... British journal of haematology 158 (1), 30-45, 2012 | 378 | 2012 |
| Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study A Sharma, NS Bhatt, A St Martin, MB Abid, J Bloomquist, RF Chemaly, ... The Lancet Haematology 8 (3), e185-e193, 2021 | 329 | 2021 |
| EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ... Bone marrow transplantation 53 (11), 1401-1415, 2018 | 329 | 2018 |
| Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation J Pidala, SJ Lee, KW Ahn, S Spellman, HL Wang, M Aljurf, M Askar, ... Blood, The Journal of the American Society of Hematology 124 (16), 2596-2606, 2014 | 281 | 2014 |
| Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study R Chopra, JD Eaton, A Grassi, M Potter, B Shaw, C Salat, P Neumeister, ... British journal of haematology 111 (4), 1122-1129, 2000 | 241 | 2000 |
| Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR J Dehn, S Spellman, CK Hurley, BE Shaw, JN Barker, LJ Burns, ... Blood, The Journal of the American Society of Hematology 134 (12), 924-934, 2019 | 239 | 2019 |
| The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation BE Shaw, TA Gooley, M Malkki, JA Madrigal, AB Begovich, MM Horowitz, ... Blood, The Journal of the American Society of Hematology 110 (13), 4560-4566, 2007 | 234 | 2007 |
| Diagnosis and management of chronic graft‐versus‐host disease FL Dignan, P Amrolia, A Clark, J Cornish, G Jackson, P Mahendra, ... British journal of haematology 158 (1), 46-61, 2012 | 206 | 2012 |
| Secondary solid cancer screening following hematopoietic cell transplantation Y Inamoto, NN Shah, BN Savani, BE Shaw, AA Abraham, IA Ahmed, ... Bone marrow transplantation 50 (8), 1013-1023, 2015 | 165 | 2015 |
| Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data RF Duarte, BE Shaw, P Marín, P Kottaridis, M Ortiz, C Morante, J Delgado, ... Bone Marrow Transplantation 46 (1), 52-58, 2011 | 156 | 2011 |
| The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation BE Shaw, R Arguello, CA Garcia‐Sepulveda, JA Madrigal British journal of haematology 150 (3), 251-258, 2010 | 144 | 2010 |
| Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program MA Pulsipher, P Chitphakdithai, BR Logan, BE Shaw, JR Wingard, ... Blood, The Journal of the American Society of Hematology 121 (1), 197-206, 2013 | 142 | 2013 |
| Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver TE Starzl, S Iwatsuki, BW Shaw Jr, MA Nalesnik, DC Farhi, DH Van Thiel Surgery, gynecology & obstetrics 162 (2), 145, 1986 | 142 | 1986 |
| Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation MA Pulsipher, P Chitphakdithai, BR Logan, WH Navarro, JE Levine, ... Blood, The Journal of the American Society of Hematology 123 (23), 3655-3663, 2014 | 141 | 2014 |
| The impact of extramedullary disease at presentation on the outcome of myeloma P Wu, FE Davies, K Boyd, K Thomas, S Dines, RM Saso, MN Potter, ... Leukemia & lymphoma 50 (2), 230-235, 2009 | 140 | 2009 |
| Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most BE Shaw, BR Logan, SR Spellman, SGE Marsh, J Robinson, J Pidala, ... Biology of Blood and Marrow Transplantation 24 (5), 1049-1056, 2018 | 132 | 2018 |
| Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant BE Shaw, GJ Mufti, S Mackinnon, JD Cavenagh, RM Pearce, KE Towlson, ... Bone marrow transplantation 42 (12), 783-789, 2008 | 130 | 2008 |
| Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides JJ Auletta, J Kou, M Chen, BE Shaw Biol Blood Marrow Transplant 26, e177-82, 2021 | 128 | 2021 |
